Skip to main content

Advertisement

Log in

The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: the REQUEST study

  • Alimmentary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Patients with reflux esophagitis (RE) in Western countries have impaired health-related quality of life (HRQOL). However, few data are available concerning HRQOL in Asian patients with RE.

Aim

To determine the demographic characteristics, HRQOL, and the impact of lansoprazole treatment in a large cohort of RE patients in Japan.

Methods

Patients with RE were enrolled. Lansoprazole was administered for 8 weeks and HRQOL assessed using the SF-8 and a newly developed questionnaire for RE-specific HRQOL (RESQ) at baseline and after 4 and 8 weeks of treatment.

Results

Among enrolled patients, 2320 patients with the Los Angeles classification grade A to D esophagitis at enrollment to the study were analyzed. A higher proportion of older women was observed (in the group of patients aged ≥60 years, 61.3% were women). Prevalence of obesity was 4.7%. At baseline, HRQOL scores of RE patients were well below the mean for the Japanese general population in all domains of the SF-8. After 8 weeks of treatment with lansoprazole, these scores significantly improved to the levels of the general population (P < 0.01). Scores of RESQ also significantly improved (P < 0.01).

Conclusions

Demographically, RE patients in Japan differ from those in Western countries with an increased proportion in older women and lower prevalence of obesity. RE has a marked negative impact on HRQOL, which is significantly improved by treatment with lansoprazole.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710–717.

    Article  PubMed  CAS  Google Scholar 

  2. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006;4:398–407.

    Article  PubMed  Google Scholar 

  3. El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007;5:17–26.

    Article  PubMed  Google Scholar 

  4. Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, Chiba T. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut 1997;41:452–458.

    Article  PubMed  CAS  Google Scholar 

  5. Lam SK, Hasan M, Sircus W, Wong J, Ong GB, Prescott RJ. Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut 1980;21:324–328.

    Article  PubMed  CAS  Google Scholar 

  6. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997;112:1448–1456.

    Article  PubMed  Google Scholar 

  7. Shimazu T, Matsui T, Furukawa K, Oshige K, Mitsuyasu T, Kiyomizu, et al. A prospective study of the prevalence of gastroesophageal reflux disease and confounding factors. J Gastroenterol 2005;40:866–872.

    Article  PubMed  Google Scholar 

  8. Furukawa N, Iwakiri R, Koyama T, Okamoto K, Yoshida T, Kashiwagi Y, et al. Proportion of reflux esophagitis in 6010 Japanese adults: prospective evaluation by endoscopy. J Gastroenterol 1999;34:441–444.

    Article  PubMed  CAS  Google Scholar 

  9. Cho YS, Choi MG, Jeong JJ, Chung WC, Lee IS, Kim SW, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol 2005;100:747–753.

    Article  PubMed  Google Scholar 

  10. Chen M, Xiong L, Chen H, Xu A, He L, Hu P. Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: a population-based study in South China. Scand J Gastroenterol 2005;40:759–767.

    Article  PubMed  Google Scholar 

  11. Yoshiike N, Kaneda F, Takimoto H. Epidemiology of obesity and public health strategies for its control in Japan. Asia Pac J Clin Nutr 2002;11(suppl 8) S727–S731.

    Article  PubMed  Google Scholar 

  12. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006;295:1549–1555.

    Article  PubMed  CAS  Google Scholar 

  13. Robinson M, Fitzgerald S, Hegedus R, Murthy A, Jokubaitis L; FAST Trial Investigators. Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis. Aliment Pharmacol Ther 2002;16:445–454.

    Article  PubMed  CAS  Google Scholar 

  14. Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease: an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003;18:767–776.

    Article  PubMed  CAS  Google Scholar 

  15. Fukuhara S, Suzukamo Y. Manual of the SF-8 Japanese version. Kyoto: Institute for Health Outcomes & Process Evaluation Research; 2004 (in Japanese).

    Google Scholar 

  16. Stanghellini V, Armstrong D, Monnikes H, Bardhan KD. Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire? Aliment Pharmacol Ther 2004;19:463–479.

    Article  PubMed  CAS  Google Scholar 

  17. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new diseasespecific questionnaire (QOLRAD). Eur J Surg Suppl 1998;583:41–49.

    PubMed  Google Scholar 

  18. Macran S, Wileman S, Barton G, Russell I; REFLUX trial group. The development of a new measure of quality of life in the management of gastro-oesophageal reflux disease: the Reflux questionnaire. Qual Life Res 2007;16:331–343.

    Article  PubMed  Google Scholar 

  19. Klinkenberg-Knol EC, Jansen JM, Festen HP, Meuwissen SG, Lamers CB. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987;1:349–351.

    Article  PubMed  CAS  Google Scholar 

  20. Feldman M, Harford WV, Fisher RS, Sampliner RE, Murray SB, Greski-Rose PA, et al. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Am J Gastroenterol 1993;88:1212–1217.

    PubMed  CAS  Google Scholar 

  21. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172–180.

    Article  PubMed  CAS  Google Scholar 

  22. Hongo M. Minimal changes in reflux esophagitis: red ones and white ones. J Gastroenterol 2006;41:95–99.

    Article  PubMed  Google Scholar 

  23. Yamaguchi T, Sugimoto T, Yamada H, Kanzawa M, Yano S, Yamauchi M, et al. The presence and severity of vertebral fractures is associated with the presence of esophageal hiatal hernia in postmenopausal women. Osteoporos Int 2002;13:331–336.

    Article  PubMed  CAS  Google Scholar 

  24. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199–211.

    PubMed  Google Scholar 

  25. Ministry of Health, Labour and Welfareof Japan. The national health and nutrition survey in Japan, 2004. Tokyo: Daiichi Publishing; 2006 (in Japanese).

    Google Scholar 

  26. Kimura T, Tsuda Y, Uchida S, Eboshida A. Association of perceived stress and stiff neck/shoulder with health status: multiple regression models by gender. Hiroshima J Med Sci 2006;55:101–107.

    PubMed  Google Scholar 

  27. Fujii T, Ogino S, Arimoto H, Irifune M, Iwata N, Ookawachi I, et al. Quality of life in patients with Japanese cedar pollinosis: using the SF-8 health status questionnaire (Japanese version) Arerugi 2006;55:1288–1294 (in Japanese with English abstract).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hongo, M., Kinoshita, Y., Miwa, H. et al. The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: the REQUEST study. J Gastroenterol 43, 920–927 (2008). https://doi.org/10.1007/s00535-008-2257-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-008-2257-7

Key words

Navigation